Benjamin M. Scirica

Sotagliflozin in Patients with Diabetes and Chronic Kidney Disease

In patients with diabetes and chronic kidney disease, with or without albuminuria, sotagliflozin resulted in a lower risk of the composite of deaths from cardiovascular causes, ...

Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes

In patients who have an acute coronary syndrome with or without ST-segment elevation, treatment with ticagrelor as compared with clopidogrel significantly reduced the rate of de...

Safety, Tolerability, and Initial Efficacy of AZD6140, the First Reversible Oral Adenosine Diphosphate Receptor Antagonist, Compared With Clopidogrel, in Patients With Non–ST-Segment Elevation Acute Coronary Syndrome

Saxagliptin and Cardiovascular Outcomes in Patients with Type 2 Diabetes Mellitus

DPP-4 inhibition with saxagliptin did not increase or decrease the rate of ischemic events, though the rate of hospitalization for heart failure was increased. Although saxaglip...